ClinicalTrials.gov record
A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
ClinicalTrials.gov ID: NCT05128825
Public ClinicalTrials.gov record NCT05128825. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
ClinicalTrials.gov public records Last synced May 6, 2026, 7:33 PM EDT
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2 Open-Label, Multicenter Study To Evaluate Efficacy And Safety Of ZN-c3 In Subjects With High-Grade Serous Ovarian, Fallopian Tube, Or Primary Peritoneal Cancer (DENALI / ZN-c3-005 / GOG-3066)
Study identification
- NCT ID
- NCT05128825
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
- Industry
- Enrollment
- 310 participants
Conditions and interventions
Interventions
- azenosertib Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 16, 2022
- Primary completion
- Nov 30, 2026
- Completion
- Jun 29, 2027
- Last update posted
- Apr 30, 2026
2022 – 2027
United States locations
- U.S. sites
- 44
- U.S. states
- 26
- U.S. cities
- 40
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site 0170-USA Mitchell Cancer Institute | Mobile | Alabama | 36604 | Recruiting |
| Site 0143 - HonorHealth | Phoenix | Arizona | 85016 | Recruiting |
| Site 0102 - University of Arizona Cancer Center | Tucson | Arizona | 85724 | Recruiting |
| Site 0258 - UC San Diego Moores Cancer Center | La Jolla | California | 92037 | Active, not recruiting |
| Site 0287 - Ridley Tree Cancer Center | Santa Barbara | California | 93105 | Active, not recruiting |
| Site 0135 - Rocky Mountain Cancer Centers | Lone Tree | Colorado | 80218 | Active, not recruiting |
| Site 0158 - Hartford HealthCare | Hartford | Connecticut | 06106 | Recruiting |
| Site 0239 - Florida Cancer Specialists - East | Daytona Beach | Florida | 32117 | Recruiting |
| Site 0173 - Mount Sinai Medical Center | Miami Beach | Florida | 33140 | Recruiting |
| Site 0308 - Advent Health | Orlando | Florida | 32803 | Recruiting |
| Site 0108 - Emory University Hospital | Atlanta | Georgia | 30322 | Recruiting |
| Site 0236 - Memorial Health | Savannah | Georgia | 31404 | Active, not recruiting |
| Site 0324 - Illinois Cancer Specialists | Niles | Illinois | 60714 | Active, not recruiting |
| Site 0284 - Community Cancer Center North | Indianapolis | Indiana | 46250 | Recruiting |
| Site 0217 - St Vincent Hospital and Health Care Centers | Indianapolis | Indiana | 46260 | Recruiting |
| Site 0251 - Norton Cancer Institute | Louisville | Kentucky | 40202 | Recruiting |
| Site 0146 - Maryland Oncology Hematology, PA | Rockville | Maryland | 20876 | Active, not recruiting |
| Site 0221 - Tufts Medical Center - PPDS | Boston | Massachusetts | 02111 | Recruiting |
| Site 0104 - Dana Farber Cancer Institute | Boston | Massachusetts | 02215 | Recruiting |
| Site 0307 - Lahey Hospital and Medical Center | Burlington | Massachusetts | 01805 | Recruiting |
| Site 0263 - Baystate Medical Center | Springfield | Massachusetts | 01199 | Recruiting |
| Site 0101 - Barbara Ann Karmanos Cancer Institute | Detroit | Michigan | 48201 | Recruiting |
| Site 0228 - Corewell Health Medical Group West | Grand Rapids | Michigan | 49503 | Recruiting |
| Site 0288 - Minnesota Oncology Hematology - Maplewood | Maplewood | Minnesota | 55109 | Recruiting |
| Site 0226 - CoxHealth | Springfield | Missouri | 65807 | Active, not recruiting |
| Site 0317 - Nebraska Methodist Hospital | Omaha | Nebraska | 68114 | Active, not recruiting |
| Site 0213 - Center of Hope | Reno | Nevada | 89511 | Recruiting |
| Site 0231 - Northwell Health Cancer Institute | Manhasset | New York | 11030 | Active, not recruiting |
| Site 0126 - Wilmot Cancer Center | Rochester | New York | 14642 | Recruiting |
| Site 0259 - Duke Cancer Center | Durham | North Carolina | 27710 | Recruiting |
| Site 0147 - Trihealth Cancer Institute - Harold and Eugen | Cincinnati | Ohio | 45242 | Recruiting |
| Site 0243 - Mark H Zangmeister Cancer Center | Columbus | Ohio | 43219 | Recruiting |
| Site 0214-Ohio State University Comprehensive Cancer Center | Hilliard | Ohio | 43026 | Recruiting |
| Site 0316 - Willamette Valley Cancer Institute/Oncology Associates of Oregon | Eugene | Oregon | 97401 | Recruiting |
| Site 0232 - University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | Recruiting |
| Site 0178 - Thomas Jefferson University | Philadelphia | Pennsylvania | 19107 | Recruiting |
| Site 0277 - Alliance Cancer Specialist, PC | Wynnewood | Pennsylvania | 19096 | Active, not recruiting |
| Site 0132 - Avera Cancer Institute | Sioux Falls | South Dakota | 57105 | Recruiting |
| Site 0103 - University of Texas MD Anderson Cancer Center | Houston | Texas | 77030 | Recruiting |
| Site 0234 - University of Texas Health, Memorial Hermann Hospital | Houston | Texas | 77030 | Recruiting |
| Site 0203 - Texas Oncology | Tyler | Texas | 75702 | Recruiting |
| Site 0295 - Virginia Oncology Associates | Chesapeake | Virginia | 23320 | Recruiting |
| Site 0322 - Inova Schar Cancer Institute | Fairfax | Virginia | 22031 | Recruiting |
| Site 0323 - Compass Oncology | Vancouver | Washington | 98684 | Active, not recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 47 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05128825, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 30, 2026 · Synced May 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05128825 live on ClinicalTrials.gov.